Medical info
Description
Vocal Characteristics
Language
EnglishVoice Age
Young Adult (18-35)Accents
North American (General) North American (US General American - GenAM)Transcript
Note: Transcripts are generated using speech recognition software and may contain errors.
Nahla Haygood, Dr Baker Cardiologists. Today in my office, I discussed with Frank and his family the reality of risk and modifiable risk. We're finding more and more data supporting. Lowering LDL decreases a patient's risk for future cardiovascular events, and as such products have become available, that can help PCSK nine inhibitors on top of maximally tolerated statin cholesterol. Medicine can reduce the patient's Elio up to 60%. That could get Frank's Eliel down to the 30 range, and that's good. Frank seems to be a good candidate for PCs canine treatment based on recommendations from the National Liberte Association. According to the latest guidelines, PCSK nine inhibitor therapy may be considered to further reduce LDL C in patients with progressive A S C V D on maximally tolerated statin therapy, with or without as atomized and on treatment L D, o. C. Greater or less than 78 milligrams per decile eater or non HDL C greater in less than 100 milligrams per decile leader. When I brought up PCSK a night inhibitors, I saw Jenny and Anne's faces light up. They done their research and it appears my recommendation aligned with what they had been reading the Grateful. There's another option out there that could help Frank's condition and are hopeful that one day he'll meet his grandchildren.